Dr Christian Behrenbruch – CEO & Managing Director – Telix is a late-stage radiopharmaceutical company developing diagnostic and therapeutic assets using Molecularly Targeted Radiation.
Views: 614
Dr Christian Behrenbruch – CEO & Managing Director – Telix is a late-stage radiopharmaceutical company developing diagnostic and therapeutic assets using Molecularly Targeted Radiation.